Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, retail pharmacy chains, and software companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.
PHSI President Tim Kosty presented at the American Society for Automation in Pharmacy (ASAP) 2015 Midyear Conference in Palm Beach, Florida. Tim provided an overview of retail pharmacy clinical services hurdles in relation to ACOs and other risk bearing stakeholders in his presentation, “Retail Pharmacy Clinical Services: Influence of ACOs & Healthcare Financing Models”. Click Read More →
PHSI Director of Business Development Fred Hamlin and PHSI Consultant Dave Schuetz will be attending the NCPDP Joint Technical Work Group Meetings November 4th and 5th at the Hyatt Regency St. Louis at the Arch – St. Louis, MO. The Work Group Meetings provide a venue for NCPDP members and industry stakeholders to come together to Read More →
Signup for free and listen to PHSI Vice President Don Dietz and Director of Business Development Fred Hamlin discuss factors influencing generic pharmaceutical pricing dynamics, impact of generic price changes, and increasing share of top pharmacy chains & effects on generic purchasing leverage.
On July 13, the Drug Enforcement Administration (DEA) announced the reinstatement of Drug Take-Back Days, with the 10th Take-Back Day scheduled for September 26, 2015 in 48 states; Take-Back Days in Pennsylvania and Delaware will take place on September 12. Visit https://www.deadiversion.usdoj.gov/SEARCH-NTBI/ to locate a collection site near you. Termination and Reinstatement of DEA-Sponsored Take-Back Read More →
On May 20, 2015, Dr. Karen Thacker of the Allegheny County Health Department issued a press release announcing a standing order to allow pharmacists in Allegheny County (Pennsylvania) to dispense intranasal and injectable naloxone without a prescription to at-risk patients and caregivers. This standing order is allowed by Pennsylvania Act 139, which was passed in Read More →
CMS issued a new guidance on biosimilar reimbursement. It sounds simple but now the drug compendia must link the biosimilar with the originator or someone else will meet this marketplace need.